IGC Pharma Announces a $3 Million Private Placement of its Common Stock – Jul 6’23

July 6, 2023

Read More »

IGC Pharma Receives Notice of Allowance for Patent on Seizures – Jun 6’23

June 6, 2023

Read More »

IGC Pharma’s Advisor and Inventor of Drug Candidate TGR-63 Receives Award

June 5, 2023

Read More »

IGC Pharma to Present at LD Micro Invitational XIII

May 18, 2023

Read More »

IGC PHARMA to Present at the Planet MicroCap Showcase VEGAS 2023

April 18, 2023

Read More »

Investor Summit March 2023

March 24, 2023

Read More »

IGC Announces Rebranding Changes Name to IGC Pharma Inc

March 20, 2023

Read More »

IGC Reports Financial Results for Third Fiscal Quarter Ended Dec. 31, 2022

February 14, 2023

Read More »

IGC to be Featured in Feb. 10 Radius Research Investor Webinar

February 8, 2023

Read More »

IGC Receives No objection letter from Health Canada JAN 4. 3023

January 4, 2023

Read More »